Elevations of DNA topoisomerase I catalytic activity and immunoprotein in human malignancies

Oncology Research

Volumn 8, Issue 1, 1996, Pages 17-25

  Bronstein, Igor B ^a   Vorobyev, Sergey ^a   Timofeev, Alexey ^a   Jolies, Christopher J ^c   Alder, Steven L ^b   Holden, Joseph A ^b  

^a ENGELHARDT INSTITUTE OF MOLECULAR BIOLOGY   (Russian Federation)

^b UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

^c NONE

Author keywords

DNA topoisomerase I; human malignancies; western blotting

Indexed keywords

CAMPTOTHECIN; DNA TOPOISOMERASE; IMMUNOGLOBULIN; MONOCLONAL ANTIBODY;

ANIMAL TISSUE; ARTICLE; CANCER CELL; CANCER CHEMOTHERAPY; CANCER TISSUE; CELL PROLIFERATION; DRUG SENSITIVITY; DRUG TARGETING; ENZYME ACTIVITY; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; LYMPHOMA; MOUSE; NONHUMAN; OVARY CARCINOMA; PRIORITY JOURNAL; RHABDOMYOSARCOMA;

EID: 0029922970     PISSN: 09650407     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Hsiang, Y-H.; Liu, L. F. Identification of mammalian DNA topoisomerase I as an intracellular target of the anticancer drug camptothecin. Cancer Res. 48:1722-1726; 1988.
2. Chen, A. Y.; Liu, L. F. DNA topoisomerases: essential enzymes and lethal targets. Annu. Rev. Pharmacol. Toxicol. 34:191-218; 1988.
3. Hsiang, Y-H.; Hertzberg, R.; Hecht, S.; Liu, L. F. Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I. J. Biol. Chem. 260:14873-14878; 1985.
4. Bjornsti, M-A.; Benedetti, P.; Viglianti, G. A.; Wang, J. C. Expression of human DNA topoisomerase I in yeast cells lacking yeast DNA topoisomerase I: restoration of sensitivity of the cells to the antitumor drug camptothecin. Cancer Res. 49:6318-6323; 1989.
5. Sugimoto, Y.; Tsukahara, S.; Oh-hara, T.; Isoe, T.; Tsuruo, T. Decreased expression of DNA topoisomerase I in camptothecin-resistant tumor cell lines as determined by a monoclonal antibody. Cancer Res. 50:6925-6930; 1990.
6. Madden, K. N.; Champoux, J. J. Overexpression of human topoisomerase I in baby hamster kidney cells; hypersensitivity of clonal isolates to camptothecin. Cancer Res. 52:525-532; 1992.
7. Giovanella, B. D.; Hinz, H. R.; Kozielski, A. J.; Stehlin, J. S. J.; Silber, R.; Potmesil, M. Complete growth inhibition of human cancer xenografts in nude mice by a treatment with 20-(S)camptothecin. Cancer Res. 51:3052-3955; 1991.
8. Giovanella, B. C.; Stehlin, J. S.; Wall, M. E.; Wani, M. C.; Nicholas, A. W.; Liu, L. F.; Silber, R.; Potmesil, M. DNA topoisomerase I-targeted chemotherapy of human colon cancer in xenografts. Science 246:1046-1048; 1989.
9. Husain, I.; Mohler J. L.; Seigler, H. F.; Besterman, J. M. Elevation of topoisomerase I messenger RNA, protein, and catalytic activity in human tumors: demonstration of tumor-type specificity and implications for cancer chemotherapy. Cancer Res. 54:539-546; 1994.
10. van der Zee, A. G. J.; Hollema, H.; de Jong, S.; Boonstra, H.; Gouw, A.; Wilemse, P. H. B.; Zijlstra, J. G.; de Vries, E. G. E. P-glycoprotein expression and DNA topoisomerase I and II activity in benign tumors of the ovary and in malignant tumors of the ovary, before and after platinum/cyclophosphamide chemotherapy. Cancer Res. 51:5915-5920; 1992.
11. Potmesil, M.; Hsiang, Y-H.; Liu, L. F.; Bank, B.; Grossberg, H.; Kirschenbaum, S.; Forlenza, T. J.; Penziner, A.; Kanganis, D.; Knowles, D.; Traganos, F.; Silber, R. Resistance of human leukemic and normal lymphocytes to drug-induced DNA cleavage and low levels of DNA topoisomerase II. Cancer Res. 48:3537-3543; 1988.
12. Mcleod, H. L.; Douglas, F.; Oates, M.; Symonds, R. P.; Prakash, D.; van der Zee, A. G. J.; Kaye, S. B.; Brown, R.; Keith, W. N. Topoisomerase I and II activity in human breast, cervix, lung, and colon cancer. Int. J. Cancer 59:607-611; 1994.
13. Shinkai, T.; Arioka, H.; Kunikane, H.; Eguchi, K.; Sasak, Y.; Tamura, T.; Ohe, Y.; Oshita, F.; Nishio, M.; Karato, A.; Okamoto, H.; Nakashima, H.; Ohmatsu, H.; Shiraishi, J.; Nomura, N.; Saijo, N. Phase I clinical trial of irinotecan (CPT-11), 7-ethyl-10-[4-(1-piperidino)-1-piperidino]-carbonyloxy-camptothecin, and cisplatin in combination with fixed dose of vindesine in advanced nonsmall cell lung cancer. Cancer Res. 44:2636-2642; 1994.
14. Karato, A.; Sasaki, Y.; Shinkai, T.; Eguchi, K.; Tamura, T.; Ohe, Y.; Oshita, F.; Nishio, M.; Kunikane, H.; Arioka, H.; Ohmatsu, H.; Nakashima, H.; Shiraishi, J.; Saijo, N. Phase I study of CPT-11 and etoposide in patients with refractory solid tumors. J. Clin. Oncol. 11:2030-2035; 1993.
15. Shimada, Y.; Yoshino, M.; Wakui, A.; Nakao, I.; Futatsuki, K.; Sakata, Y.; Kambe, M.; Taguchi, T.; Ogawa, N.; CPT-11 gastrointestinal cancer study group. Phase II study of CPT-11, a new camptothecin derivative, in metastatic colorectal cancer. J. Clin. Oncol. 11:909-913; 1993.
16. Duguet, M.; Lavenot, C.; Harper, F.; Mirambeau, G.; DeRecondo, A. DNA topoisomerases from rat liver, physiological variations. Nucleic Acids Res. 11:1058-1075; 1983.
17. Heck, M. M. S.; Hittelman, W.; Earnshaw, W. C. Differential expression of DNA topoisomerases I and II during the eukaryotic cell cycle. Proc. Natl. Acad. Sci. USA 85:1086-1090; 1988.
18. Hsiang, Y-H.; Wu, H-Y.; Liu, L. F. Proliferation-dependent regulation of DNA topoisomerase II in cultured human cells. Cancer Res. 48:3230-3235; 1988.
19. Hwong, C-L.; Chen, C-Y.; Shang, H-F.; Hwang, J. Increased synthesis and degradation of DNA topoisomerase I during the initial phase of human T lymphocyte proliferation. J. Biol. Chem. 266:18982-18986; 1993.
20. Juenke, J. M.; Holden, J. A. The distribution of DNA topoisomerase II isoforms in differentiated adult mouse tissues. Biochim. Biophys. Acta 1216:191-196; 1993.
21. Maniatis, T.; Fritsch, E. F.; Sambrook, J. Large-scale isolation of plasmid DNA. In Molecular Cloning. Cold Spring Harbor: Cold Spring Harbor Laboratory Press; 1982:pp. 86-96.
22. Tsai-Pflugfelder, M. T.; Liu, L. F.; Liu, A. A.; Tewey, K. M.; Whang-Peng, J.; Knutsen, T.; Huebner, K.; Croce, C. M. N.; Wang, J. C. Cloning and sequencing of cDNA encoding human DNA topoisomerase II and localization of the gene to chromosome region 17q21-22. Proc. Natl. Acad. Sci. USA 85:717-718; 1988.
23. Schulman, M.; Wilde, C. D.; Kohler, G. A. A better cell line for making hybridomas secreting specific antibodies. Nature 276:269-270; 1979.
24. Kohler, G.; Milstein, C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256:495-497; 1975.
25. Herlyn, D.; Lubeck, M.; Sears, H.; Koprowski, H. Specific detection of anti-idiotypic immune responses in cancer patients treated with monoclonal antibody. J. Immunol. Meth. 85:27-38; 1975.
26. Holden, J. A.; Rolfson, D. H.; Wittwer, C. T. The distribution of immunoreactive topoisomerase II protein in human tissues and neoplasms. Oncol. Res. 4:157-166; 1992.
27. Holden, J. A.; Rolfson, D. H.; Low, R. L. DNA topoisomerase I from human placenta. Biochim. Biophys. Acta 1049:303-310; 1990.
28. Bronstein, I. B.; Gromova, I.; Razin, S. Specific cleavage of chicken αA-globin and human c-Ha-ras genes by two molecular forms of calf thymus topoisomerase I. Mol. Cell. Biochem. 101:115-124; 1991.
29. Bradford, M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Anal. Biochem. 72:248-254; 1976.
30. van der Zee, A. G. J.; de Jong, S.; Keith, W. N.; Hollema, H.; Boonstra, H.; de Vries, G. E. Quantitative and qualitative aspects of topoisomerase I and II-α and - β in untreated and platinum/cyclophosphamide treated malignant ovarian tumors. Cancer Res. 54:749-755:1994.
31. Liu, L. F.; Miller, K. G. Eukaryotic DNA topoisomerases: two forms of type I DNA topoisomerases from HeLa cell nuclei. Proc. Natl. Acad. Sci. USA 78:3487-3491; 1981.
32. Potmesil, M. Camptothecins: from bench research to hospital wards. Cancer Res. 54:1431-1439; 1994.
33. Durban, E.; Goodenough, M.; Mills, J.; Busch, H. Topoisomerase I phosphorylation in vitro and in rapidly growing Novikoff hepatoma cells. EMBO J. 4:2921-2926; 1985.
34. Kasid, U. N.; Halligan, B.; Liu, L. F.; Dritschilo, A.; Smulson, M. Poly(ADP-ribose)-mediated posttranslational modification of chromatin-associated human topoisomerase I. J. Biol. Chem. 264:18687-18692; 1989.
35. Low, R. L.; Holden, J. H. Inhibition of HeLa cell DNA topoisomerase I by ATP and phosphate. Nucleic Acids Res. 13:6999-7014; 1985.
36. Zhang, H.; D'Arpa, P.; Liu, L. F. A model for tumor cell killing by topoisomerase poisons. Cancer Cells 2:23-27; 1990.
37. Silber, R.; Degar, B.; Costin, D.; Newcomb, E. W.; Mani, M.; Rosenberg, C. R.; Morse, L.; Drygas, J. C.; Canellakis, Z. N.; Potmesil, M. Chemosensitivity of lymphocytes from patients with B-cell chronic lymphocytic leukemia to chlorambucil, fludarabine, and camptothecin analogs. Blood 84:3440-3446; 1994.